ImmuCell Corporation (ICCC) earnings · rev $27.6M
These earnings events as JSON? API free 100/dayImmuCell Corporation (ICCC) is a biotechnology company listed on US.
This ICCC earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ICCC revenue for 2025-12-31 was $27.6M. Net income was -$1.0M. Revenue was up 58.2% from 2023-12-31 to 2025-12-31. ICCC currently screens at market cap $58.9M.
When the next ICCC 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 58.2% from 2023-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full ICCC research stays on the stock page; the tape stays on the quote page.
ICCC earnings FAQ
What are ICCC's latest revenue and net income?
Latest cached ImmuCell Corporation (ICCC) revenue for Dec 31, 2025 was $27.6M. Net income was -$1.0M. Statements: https://lician.com/financials/iccc
What is ICCC's latest diluted EPS?
Latest cached ImmuCell Corporation (ICCC) diluted EPS for Dec 31, 2025 was -$0.12.
What period does the latest ICCC earnings print cover?
The latest cached ImmuCell Corporation (ICCC) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2023.
How did ICCC revenue change from the prior cached period?
Cached ImmuCell Corporation (ICCC) revenue was up 58.2% from $17.5M (Dec 31, 2023) to $27.6M (Dec 31, 2025). Statements: https://lician.com/financials/iccc
Where are ICCC earnings listed?
Cached earnings facts for ImmuCell Corporation (ICCC) are listed at https://lician.com/earnings/iccc. Statements: https://lician.com/financials/iccc
Not investment advice.